文献速递外周动脉疾病

膝下慢性危及肢体缺血血运重建结局的系统评价与Meta分析

A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
PubMed 文献 · J Vasc Surg · 2018-05-24

该系统评价检索至2017年5月7日的多个数据库,纳入44项前瞻性研究、8602例膝下慢性危及肢体缺血(CLTI)患者,采用随机效应Meta分析汇总结局。结果显示大隐静脉旁路1年和2年通畅率最高(一期87%、78%;二期94%、87%),人工血管旁路在膝下目标血管的截肢与通畅结局明显劣于静脉旁路,药物洗脱支架在膝下动脉的通畅率优于裸金属支架(1年一期通畅73% vs 50%)。纳入研究总体偏倚风险中至高等、证据质量低。

要点

  • 围手术期(30天)死亡、截肢和主要不良心脏事件在各治疗方式间大致相似。
  • 大隐静脉旁路1年和2年一期通畅率分别为87%和78%,二期分别为94%和87%。
  • 人工血管旁路在膝下目标血管的截肢与通畅结局明显劣于静脉旁路。

核心结论

  • 当前指导CLTI治疗决策的证据存在重大局限,尤其对经腔内方式治疗的严重解剖病变模式。
  • 各治疗方式的围手术期(30天)死亡、截肢和主要不良心脏事件大致相似。
  • 大隐静脉旁路通畅率最高,而人工血管旁路至膝下目标血管的通畅率和保肢率均明显较差。
  • 在腔内干预中,经皮腔内血管成形术与药物洗脱支架对膝下局灶性病变似乎相当,但无研究纳入长段胫动脉病变。
  • 患者风险、肢体威胁严重程度和所治疗解剖的异质性使当前文献结局的直接比较具有挑战性。

研究设计与样本

  • 系统评价与随机效应Meta分析,检索多个数据库至2017年5月7日。
  • 纳入至少1年随访、评估成人CLTI膝下血运重建患者相关结局的前瞻性研究。
  • 由独立评审对逐篇筛选文章并提取数据。
  • 共纳入44项研究,入组8602例患者。

主要发现

  • 围手术期结局(死亡、截肢、主要不良心脏事件)在各治疗方式间相似。
  • 膝下病变患者大隐静脉旁路1年和2年一期通畅率分别为87%和78%,二期分别为94%和87%,高于所有其他干预。
  • 人工血管旁路在截肢和通畅结局方面明显劣于静脉旁路,尤其对膝下目标血管2年及以后。
  • 药物洗脱支架在膝下动脉的一期通畅率优于裸金属支架(1年73% vs 50%),至少与球囊血管成形术相当(一期通畅66%)。
  • 2年生存率、大截肢率和无截肢生存率在腔内干预与静脉旁路之间大致相似,人工血管旁路肢体丢失率更高。

关键数值与推荐

  • 大隐静脉旁路1年一期通畅率87%、二期94%;2年一期78%、二期87%。
  • 药物洗脱支架膝下动脉1年一期通畅率73% vs 裸金属支架50%。
  • 球囊血管成形术一期通畅率66%。
  • 纳入研究总体偏倚风险中至高等,证据质量低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入研究总体偏倚风险中至高等,证据质量低。
  • 患者风险、肢体威胁严重程度和所治疗解剖的异质性使当前文献结局的直接比较具有挑战性。
  • 无研究纳入长段胫动脉病变。
  • 当前指导CLTI治疗决策的证据存在重大局限,尤其对经腔内方式治疗的严重解剖病变模式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal strategy for revascularization in infrainguinal chronic limb-threatening ischemia (CLTI) remains debatable. Comparative trials are scarce, and daily decisions are often made using anecdotal or low-quality evidence. METHODS: We searched multiple databases through May 7, 2017, for prospective studies with at least 1-year follow-up that evaluated patient-relevant outcomes of infrainguinal revascularization procedures in adults with CLTI. Independent pairs of reviewers selected articles and extracted data. Random-effects meta-analysis was used to pool outcomes across studies. RESULTS: We included 44 studies that enrolled 8602 patients. Periprocedural outcomes (mortality, amputation, major adverse cardiac events) were similar across treatment modalities. Overall, patients with infrapopliteal disease had higher patency rates of great saphenous vein graft at 1 and 2 years (primary: 87%, 78%; secondary: 94%, 87%, respectively) compared with all other interventions. Prosthetic bypass outcomes were notably inferior to vein bypass in terms of amputation and patency outcomes, especially for below knee targets at 2 years and beyond. Drug-eluting stents demonstrated improved patency over bare-metal stents in infrapopliteal arteries (primary patency: 73% vs 50% at 1 year), and was at least comparable to balloon angioplasty (66% primary patency). Survival, major amputation, and amputation-free survival at 2 years were broadly similar between endovascular interventions and vein bypass, with prosthetic bypass having higher rates of limb loss. Overall, the included studies were at moderate to high risk of bias and the quality of evidence was low. CONCLUSIONS: There are major limitations in the current state of evidence guiding treatment decisions in CLTI, particularly for severe anatomic patterns of disease treated via endovascular means. Periprocedural (30-day) mortality, amputation, and major adverse cardiac events are broadly similar across modalities. Patency rates are highest for saphenous vein bypass, whereas both patency and limb salvage are markedly inferior for prosthetic grafting to below the knee targets. Among endovascular interventions, percutaneous transluminal angioplasty and drug-eluting stents appear comparable for focal infrapopliteal disease, although no studies included long segment tibial lesions. Heterogeneity in patient risk, severity of limb threat, and anatomy treated renders direct comparison of outcomes from the current literature challenging. Future studies should incorporate both limb severity and anatomic staging to best guide clinical decision making in CLTI.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Almasri J, Adusumalli J, Asi N, et al. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg. 2018. PMID: 29804736. doi:10.1016/j.jvs.2018.01.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。